3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: November 4, 2019
Period of Report: October 28, 2019
Accession Number: 0001127602-19-031730

View Document ↗ View on SEC.gov ↗